Great. That's a start. Now according to your article, the Epipen is manufactured by Mylan. Here is their profit margin:
Current and historical gross margin, operating margin and net profit margin for Mylan (MYL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Mylan net profit margin as of September 30, 2019 is 0.42%.
Mylan Profit Margin 2006-2019 | MYL
.42% I believe the banks are offering more for a savings account. Now let me ask: would you invest in this company?
You see, pharmaceutical companies invest a ton of money to satisfy our FDA. Hundreds of millions of dollars and years of red tape and testing need to take place to put a drug into market. When they make all those investments, and the FDA disapproves their drug, they need to increase the prices on their existing drugs.
Included in that cost is an intrinsic liability cost. When you put drugs out on the market, somebody is going to have a problem with it. When they do, the ambulance chasers are front and center to sue your company. Just look at what they did to the company that produces opioid products.
But of course, the reporters who tell you it only costs X to produce, but they sell it for Y, leave a whole lot of factors out of the mix.